# Optical Coherence Tomography Assessment of Intimal Tissue and Malapposition

> **NCT01137019** · PHASE3 · UNKNOWN · sponsor: **Dr Peter Barlis** · enrollment: 80 (estimated)

## Conditions studied

- Coronary Heart Disease

## Interventions

- **DEVICE:** Biolimus-eluting stent
- **DEVICE:** Everolimus-eluting coronary stent

## Key facts

- **NCT ID:** NCT01137019
- **Lead sponsor:** Dr Peter Barlis
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-10
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2014-08-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01137019

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01137019, "Optical Coherence Tomography Assessment of Intimal Tissue and Malapposition". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01137019. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*